Abstract:PurposeHypofractionated radiotherapy of prostate cancer is gaining clinical acceptance given its potential increase in therapeutic ratio and evidence for noninferiority and lack of added late toxicities compared to conventional fractionation. However, concerns have been raised that smaller number of fractions might lead to larger dosimetric influence by interfractional motion. We aim to compare the effect of these variations on hypofractionated pencil beam scanning (PBS) proton therapy and volumetric modulated arc therapy (VMAT) for localized prostate cancer.MethodsWeekly CT images were acquired for 6 patients participating in a randomized clinical trial. PBS plans featuring bilateral (BL) and a combination of lateral and anterior-oblique beams (AOL), and VMAT plans were created. All patients were treated to a conventional 79.2Gy total dose in 44 fractions. For this study, hypofractionated dose to the prostate gland was 51.6Gy in 12 fractions or 36.25Gy in 5 fractions, and 32.8, and 23.1Gy to proximal seminal vesicles, respectively. Patients were simulated with endorectal balloons to aid gland immobilization. Three fiducial markers were implanted for setup guidance. All plans were recomputed on the weekly CT images after aligning with the simulation CT. The entire set of 9 CT images was used for dose recalculation for 12-fraction and only 5 used for the 5-fraction case. Adaptive range adjustments were applied to anterior-oblique beams assuming clinical availability of invivo range verification. Fractional doses were summed using deformable dose accumulation to approximate the delivered dose. Biologically equivalent dose to 2Gy(EQD2) was calculated assuming / of 1.5Gy for prostate and 3Gy for bladder and rectum.ResultsThe median delivered prostate D-98 was 0.13/0.14/0.13Gy(EQD2) smaller than planned for PBS-BL, 0.13/0.27/0.17Gy(EQD2) for PBS-AOL and 0.59/0.66/0.59Gy(EQD2) for VMAT, for 44/12/5 fractions, respectively. The largest D-98 reduction was 1.5 and 3.5Gy(EQD2) for CTV1 and CTV2, respectively. Target dose degradation was comparable for all fractionation schemes within each modality. The maximum increase in rectum D-2 was 0.98Gy(EQD2) for a 5-fraction PBS case.ConclusionsThe robustness of PBS and VMAT were comparable for all patients for the studied fractionations. The delivered target dose generally remained within clinical tolerance and the deviations were relatively minor for both fractionation schemes. The delivered OAR dose stayed in compliance with the RTOG hypofractionation constraints for all cases.

The Peaks and Valleys of Photon Versus Proton Spatially Fractionated Radiotherapy

The role of radioprotective spacers in clinical practice: a review

Spatially fractionated radiation therapy: a critical review on current status of clinical and preclinical studies and knowledge gaps

Divide and conquer: spatially fractionated radiation therapy

Impact Of Interfractional Motion On Hypofractionated Pencil Beam Scanning Proton Therapy And Vmat Delivery For Prostate Cancer

Spatially Fractionated Radiotherapy in the Era of Immunotherapy

On the significance of the different geometrical and dosimetric parameters in microbeam and minibeam radiation therapy a retrospective evaluation

Assessing dosimetric advancements in spatially fractionated radiotherapy: From grids to lattices

Overview and recommendations for prospective multi-institutional clinical trials of Spatially Fractionated Radiation Therapy (SFRT)

Computational Approach for Spatially Fractionated Radiation Therapy (SFRT) and Immunological Response in Precision Radiation Therapy

Precision Radiation for Brain Metastases With a Focus on Hypofractionated Stereotactic Radiosurgery

Recent Progress in Pencil Beam Scanning FLASH Proton Therapy: A Narrative Review

Proton Pencil-Beam Scanning Stereotactic Body Radiation Therapy and Hypofractionated Radiation Therapy for Thoracic Malignancies: Patterns of Practice Survey and Recommendations for Future Development from NRG Oncology and PTCOG

Dosimetric evaluation of light ion beams for spatially fractionated radiation therapy: a Geant4 Monte Carlo study

Prospect of radiotherapy technology development in the era of immunotherapy

Practice Patterns of Spatially Fractionated Radiation Therapy: A Clinical Practice Survey

Proton Radiosurgery: Current Concepts and Limitations for CNS Radiosurgery

Proton therapy for prostate cancer: current state and future perspectives

Proton beams in cancer treatments: Clinical outcomes and dosimetric comparisons with photon therapy

[Spatially fractionated radiotherapy : introduction into clinical practice]